spacer
spacer

PDBsum entry 1ej9

Go to PDB code: 
protein dna_rna links
Isomerase/DNA PDB id
1ej9

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
483 a.a. *
DNA/RNA
Waters ×353
* Residue conservation analysis
PDB id:
1ej9
Name: Isomerase/DNA
Title: Crystal structure of human topoisomerase i DNA complex
Structure: DNA (5'- d( C Ap Ap Ap Ap Ap Gp Ap Cp Tp Cp Ap Gp Ap Ap Ap Ap Ap Tp Tp Tp Tp T )-3'). Chain: c. Engineered: yes. DNA (5'- d( C Ap Ap Ap Ap Ap Tp Tp Tp Tp Tp Cp Tp Gp Ap Gp Tp Cp Tp Tp Tp Tp T )-3'). Chain: d.
Source: Synthetic: yes. Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell: sf9 insect cells
Biol. unit: Trimer (from PQS)
Resolution:
2.60Å     R-factor:   0.214     R-free:   0.281
Authors: M.R.Redinbo,J.J.Champoux,W.G.Hol
Key ref:
M.R.Redinbo et al. (2000). Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry, 39, 6832-6840. PubMed id: 10841763 DOI: 10.1021/bi992690t
Date:
01-Mar-00     Release date:   03-Aug-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P11387  (TOP1_HUMAN) -  DNA topoisomerase 1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
765 a.a.
483 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

DNA/RNA chains
  A-A-A-A-A-G-A-C-T-C-A-G-A-A-A-A-A-T-T-T-T-T 22 bases
  A-A-A-A-A-T-T-T-T-T-C-T-G-A-G-T-C-T-T-T-T-T 22 bases

 Enzyme reactions 
   Enzyme class: E.C.5.6.2.1  - Dna topoisomerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1021/bi992690t Biochemistry 39:6832-6840 (2000)
PubMed id: 10841763  
 
 
Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA.
M.R.Redinbo, J.J.Champoux, W.G.Hol.
 
  ABSTRACT  
 
Human topoisomerase I helps to control the level of DNA supercoiling in cells and is vital for numerous DNA metabolic events, including replication, transcription, and recombination. The 2.6 A crystal structure of human topoisomerase I in noncovalent complex with a DNA duplex containing a cytosine at the -1 position of the scissile strand rather than the favored thymine is reported. The hydrogen bond between the O2 position of this -1 base and the epsilon-amino of the conserved Lys-532 residue, the only base-specific contact observed previously in the human topoisomerase I-DNA interaction, is maintained in this complex. Several unique features of this structure, however, have implications for the DNA-binding and active-site mechanisms of the enzyme. First, the ends of the DNA duplex were observed to shift by up to 5.4 A perpendicular to the DNA helical axis relative to structures reported previously, suggesting a novel degree of plasticity in the interaction between human topoisomerase I and its DNA substrate. Second, 12 additional residues at the NH(2) terminus of the protein (Trp-203-Gly-214) could be built in this structure, and they were found to pack against the putative hinge region implicated in the clamping of the enzyme around duplex DNA. Third, a water molecule was observed adjacent to the scissile phosphate and the active-site residues; the potential specific base character of this solvent molecule in the active-site mechanism of the enzyme is discussed. Fourth, the scissile phosphate group was found to be rotated by 75 degrees, bringing Lys-532 into hydrogen-bonding distance of one of the nonbridging phosphate oxygens. This orientation of the scissile phosphate group implicates Lys-532 as a fifth active-site residue, and also mimics the orientation observed for the 3'-phosphotyrosine linkage in the covalent human topoisomerase I-DNA complex structure. The implications of these structural features for the mechanism of the enzyme are discussed, including the potential requirement for a rotation of the scissile phosphate group during DNA strand cleavage and covalent attachment.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21406224 A.Alam, M.Goyal, M.S.Iqbal, S.Bindu, S.Dey, C.Pal, P.Maity, N.M.Mascarenhas, N.Ghoshal, and U.Bandyopadhyay (2011).
Cysteine-3 and cysteine-4 are essential for the thioredoxin-like oxidoreductase and antioxidant activities of Plasmodium falciparum macrophage migration inhibitory factor.
  Free Radic Biol Med, 50, 1659-1668.  
20854710 W.Yang (2011).
Nucleases: diversity of structure, function and mechanism.
  Q Rev Biophys, 44, 1.  
20200034 C.García-Estrada, C.F.Prada, C.Fernández-Rubio, F.Rojo-Vázquez, and R.Balaña-Fouce (2010).
DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.
  Proc Biol Sci, 277, 1777-1787.  
19883377 C.Tesauro, P.Fiorani, I.D'Annessa, G.Chillemi, G.Turchi, and A.Desideri (2010).
Erybraedin C, a natural compound from the plant Bituminaria bituminosa, inhibits both the cleavage and religation activities of human topoisomerase I.
  Biochem J, 425, 531-539.  
20532182 G.Mancini, I.D'Annessa, A.Coletta, N.Sanna, G.Chillemi, and A.Desideri (2010).
Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.
  PLoS One, 5, e10934.  
20152159 K.Perry, Y.Hwang, F.D.Bushman, and G.D.Van Duyne (2010).
Insights from the structure of a smallpox virus topoisomerase-DNA transition state mimic.
  Structure, 18, 127-137.
PDB code: 3igc
19472416 C.Punchihewa, M.Carver, and D.Yang (2009).
DNA sequence selectivity of human topoisomerase I-mediated DNA cleavage induced by camptothecin.
  Protein Sci, 18, 1326-1331.  
19589806 J.Malina, O.Vrana, and V.Brabec (2009).
Mechanistic studies of the modulation of cleavage activity of topoisomerase I by DNA adducts of mono- and bi-functional PtII complexes.
  Nucleic Acids Res, 37, 5432-5442.  
19551725 L.Shuai, S.Wang, L.Zhang, B.Fu, and X.Zhou (2009).
Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
  Chem Biodivers, 6, 827-837.  
19452556 O.Szklarczyk, K.Staroń, and M.Cieplak (2009).
Native state dynamics and mechanical properties of human topoisomerase I within a structure-based coarse-grained model.
  Proteins, 77, 420-431.  
19688808 Z.Liu, R.Meng, Y.Zu, Q.Li, and L.Yao (2009).
Imaging and studying human topoisomerase I on mica surfaces in air and in liquid by atomic force microscopy.
  Scanning, 31, 160-166.  
18755053 A.J.Schoeffler, and J.M.Berger (2008).
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.
  Q Rev Biophys, 41, 41.  
18186598 C.A.Prata, X.X.Zhang, D.Luo, T.J.McIntosh, P.Barthelemy, and M.W.Grinstaff (2008).
Lipophilic peptides for gene delivery.
  Bioconjug Chem, 19, 418-420.  
18157856 F.Animati, M.Berettoni, M.Bigioni, M.Binaschi, P.Felicetti, L.Gontrani, O.Incani, A.Madami, E.Monteagudo, L.Olivieri, S.Resta, C.Rossi, and A.Cipollone (2008).
Synthesis, biological evaluation, and molecular modeling studies of rebeccamycin analogues modified in the carbohydrate moiety.
  ChemMedChem, 3, 266-279.  
18765473 G.Chillemi, I.D'Annessa, P.Fiorani, C.Losasso, P.Benedetti, and A.Desideri (2008).
Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations.
  Nucleic Acids Res, 36, 5645-5651.  
18693244 K.Palle, L.Pattarello, M.van der Merwe, C.Losasso, P.Benedetti, and M.A.Bjornsti (2008).
Disulfide Cross-links Reveal Conserved Features of DNA Topoisomerase I Architecture and a Role for the N Terminus in Clamp Closure.
  J Biol Chem, 283, 27767-27775.  
17355975 D.Montaudon, K.Palle, L.P.Rivory, J.Robert, C.Douat-Casassus, S.Quideau, M.A.Bjornsti, and P.Pourquier (2007).
Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505.
  J Biol Chem, 282, 14403-14412.  
17439970 G.Chillemi, A.Bruselles, P.Fiorani, S.Bueno, and A.Desideri (2007).
The open state of human topoisomerase I as probed by molecular dynamics simulation.
  Nucleic Acids Res, 35, 3032-3038.  
18254239 I.Choi, C.Kim, and S.Choi (2007).
Binding mode analysis of topoisomerase inhibitors, 6-arylamino-7-chloro-quinazoline-5,8-diones, within the cleavable complex of human topoisomerase I and DNA.
  Arch Pharm Res, 30, 1526-1535.  
17827209 R.F.Frøhlich, C.Veigaard, F.F.Andersen, A.K.McClendon, A.C.Gentry, A.H.Andersen, N.Osheroff, T.Stevnsner, and B.R.Knudsen (2007).
Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal.
  Nucleic Acids Res, 35, 6170-6180.  
16368685 A.Patel, S.Shuman, and A.Mondragón (2006).
Crystal structure of a bacterial type IB DNA topoisomerase reveals a preassembled active site in the absence of DNA.
  J Biol Chem, 281, 6030-6037.
PDB code: 2f4q
16895336 J.T.Stivers, and R.Nagarajan (2006).
Probing enzyme phosphoester interactions by combining mutagenesis and chemical modification of phosphate ester oxygens.
  Chem Rev, 106, 3443-3467.  
16885024 K.Perry, Y.Hwang, F.D.Bushman, and G.D.Van Duyne (2006).
Structural basis for specificity in the poxvirus topoisomerase.
  Mol Cell, 23, 343-354.
PDB codes: 2h7f 2h7g
15711017 B.B.Das, N.Sen, S.B.Dasgupta, A.Ganguly, and H.K.Majumder (2005).
N-terminal region of the large subunit of Leishmania donovani bisubunit topoisomerase I is involved in DNA relaxation and interaction with the smaller subunit.
  J Biol Chem, 280, 16335-16344.  
15830206 J.B.Leppard, and J.J.Champoux (2005).
Human DNA topoisomerase I: relaxation, roles, and damage control.
  Chromosoma, 114, 75-85.  
16314322 L.Sari, and I.Andricioaei (2005).
Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation.
  Nucleic Acids Res, 33, 6621-6634.  
15837190 L.Tian, C.D.Claeboe, S.M.Hecht, and S.Shuman (2005).
Mechanistic plasticity of DNA topoisomerase IB: phosphate electrostatics dictate the need for a catalytic arginine.
  Structure, 13, 513-520.  
16277689 P.L.Carl, B.R.Temple, and P.L.Cohen (2005).
Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity.
  Arthritis Res Ther, 7, R1360-R1374.  
15347588 G.Chillemi, M.Redinbo, A.Bruselles, and A.Desideri (2004).
Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics.
  Biophys J, 87, 4087-4097.  
14594810 H.Interthal, P.M.Quigley, W.G.Hol, and J.J.Champoux (2004).
The role of lysine 532 in the catalytic mechanism of human topoisomerase I.
  J Biol Chem, 279, 2984-2992.
PDB code: 1r49
15494452 J.J.Vermeersch, S.Christmann-Franck, L.V.Karabashyan, S.Fermandjian, G.Mirambeau, and P.A.Der Garabedian (2004).
Pyridoxal 5'-phosphate inactivates DNA topoisomerase IB by modifying the lysine general acid.
  Nucleic Acids Res, 32, 5649-5657.  
15139806 K.D.Corbett, and J.M.Berger (2004).
Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.
  Annu Rev Biophys Biomol Struct, 33, 95.  
14725763 L.Tian, C.D.Claeboe, S.M.Hecht, and S.Shuman (2004).
Remote phosphate contacts trigger assembly of the active site of DNA topoisomerase IB.
  Structure, 12, 31-40.  
15498925 S.Antony, J.A.Theruvathu, P.J.Brooks, D.T.Lesher, M.Redinbo, and Y.Pommier (2004).
Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.
  Nucleic Acids Res, 32, 5685-5692.  
15469908 S.Antony, P.B.Arimondo, J.S.Sun, and Y.Pommier (2004).
Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures.
  Nucleic Acids Res, 32, 5163-5173.  
12482574 C.Bailly (2003).
Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs.
  Crit Rev Oncol Hematol, 45, 91.  
12595561 G.Chillemi, P.Fiorani, P.Benedetti, and A.Desideri (2003).
Protein concerted motions in the DNA-human topoisomerase I complex.
  Nucleic Acids Res, 31, 1525-1535.  
12533542 J.E.Chrencik, A.B.Burgin, Y.Pommier, L.Stewart, and M.R.Redinbo (2003).
Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex.
  J Biol Chem, 278, 12461-12466.
PDB code: 1nh3
14654701 M.O.Christensen, H.U.Barthelmes, F.Boege, and C.Mielke (2003).
Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.
  Nucleic Acids Res, 31, 7255-7263.  
12853620 P.B.Arimondo, S.Angenault, L.Halby, A.Boutorine, F.Schmidt, C.Monneret, T.Garestier, J.S.Sun, C.Bailly, and C.Hélène (2003).
Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugates.
  Nucleic Acids Res, 31, 4031-4040.  
12716882 Y.Chen, and P.A.Rice (2003).
The role of the conserved Trp330 in Flp-mediated recombination. Functional and structural analysis.
  J Biol Chem, 278, 24800-24807.
PDB code: 1p4e
12598365 Y.Chen, and P.A.Rice (2003).
New insight into site-specific recombination from Flp recombinase-DNA structures.
  Annu Rev Biophys Biomol Struct, 32, 135-159.  
11756402 B.O.Krogh, and S.Shuman (2002).
Proton relay mechanism of general acid catalysis by DNA topoisomerase IB.
  J Biol Chem, 277, 5711-5714.  
11756434 C.Marchand, P.Pourquier, G.S.Laco, N.Jing, and Y.Pommier (2002).
Interaction of human nuclear topoisomerase I with guanosine quartet-forming and guanosine-rich single-stranded DNA and RNA oligonucleotides.
  J Biol Chem, 277, 8906-8911.  
12209008 D.T.Lesher, Y.Pommier, L.Stewart, and M.R.Redinbo (2002).
8-Oxoguanine rearranges the active site of human topoisomerase I.
  Proc Natl Acad Sci U S A, 99, 12102-12107.
PDB code: 1lpq
11724801 P.B.Arimondo, A.Boutorine, B.Baldeyrou, C.Bailly, M.Kuwahara, S.M.Hecht, J.S.Sun, T.Garestier, and C.Hélène (2002).
Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specific DNA cleavage by topoisomerase I.
  J Biol Chem, 277, 3132-3140.  
11832494 Y.Pommier, G.Kohlhagen, G.S.Laco, H.Kroth, J.M.Sayer, and D.M.Jerina (2002).
Different effects on human topoisomerase I by minor groove and intercalated deoxyguanosine adducts derived from two polycyclic aromatic hydrocarbon diol epoxides at or near a normal cleavage site.
  J Biol Chem, 277, 13666-13672.  
11423431 G.Chillemi, T.Castrignanò, and A.Desideri (2001).
Structure and hydration of the DNA-human topoisomerase I covalent complex.
  Biophys J, 81, 490-500.  
11395412 J.J.Champoux (2001).
DNA topoisomerases: structure, function, and mechanism.
  Annu Rev Biochem, 70, 369-413.  
  11090626 Y.Chen, U.Narendra, L.E.Iype, M.M.Cox, and P.A.Rice (2000).
Crystal structure of a Flp recombinase-Holliday junction complex: assembly of an active oligomer by helix swapping.
  Mol Cell, 6, 885-897.
PDB code: 1flo
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer